June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Peripheral Monocyte Subset-Derived Macrophages Show Distinct Expression Kinetics of Immune Biomarkers Associated with Ocular Autoimmunity
Author Affiliations & Notes
  • Susan Hannes
    Clinical Immunology, National Eye Institute, Bethesda, MD
  • Baoying Liu
    Clinical Immunology, National Eye Institute, Bethesda, MD
  • Zhiyu Li
    Clinical Immunology, National Eye Institute, Bethesda, MD
  • Diamond Ling
    Clinical Immunology, National Eye Institute, Bethesda, MD
  • H Nida Sen
    Clinical Immunology, National Eye Institute, Bethesda, MD
  • Robert B Nussenblatt
    Clinical Immunology, National Eye Institute, Bethesda, MD
  • Footnotes
    Commercial Relationships Susan Hannes, None; Baoying Liu, None; Zhiyu Li, None; Diamond Ling, None; H Nida Sen, None; Robert Nussenblatt, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 884. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Susan Hannes, Baoying Liu, Zhiyu Li, Diamond Ling, H Nida Sen, Robert B Nussenblatt; Peripheral Monocyte Subset-Derived Macrophages Show Distinct Expression Kinetics of Immune Biomarkers Associated with Ocular Autoimmunity. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):884.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Human peripheral blood monocytes are precursors of some tissue-resident macrophages and have been implicated in the pathogenesis of non-infectious uveitis. They can be categorized into three subgroups: CD14++CD16- (classical), CD14++CD16+ (intermediate), and CD14+CD16++ (non-classical). Previously, we observed that monocytes isolated from the circulating blood of non-infectious uveitis patients exhibit a skewed phenotype toward an elevated level of the CD14++CD16+ subset. However, the destiny of these monocyte subsets after differentiation has not been fully investigated. Here, we sought to evaluate the expression kinetics of immune biomarkers associated with non-infectious uveitis in both M1 (pro-inflammatory) and M2 (alternative) macrophages in vitro.

Methods: Human peripheral blood mononuclear cells (PBMCs) were isolated from the peripheral blood of healthy donors and uveitis patients using a Ficoll gradient centrifugation protocol. Subsets of monocytes were purified by flow cytometry (BDFACSAria II) based on CD14 and CD16 staining. The subsets were differentiated over a time course using GM-CSF and M-CSF to produce M1 and M2 macrophages, respectively. An Annexin V Apoptosis Assay was used to monitor viability. The following cell surface markers were assayed with flow cytometry: CD1a, CD11b, CD11c, CD69, CD80, CD86, and CD163.

Results: We observed a time dependent effect in biomarker changes during polarization procedures using either GM-CSF or M-CSF by monitoring cell-surface marker changes. During M1 and M2 differentiation conditions, marker expression levels varied, with perceptible increases in CD80, CD86, and CD163 for GM-CSF differentiated<br /> CD14++CD16- and CD14++CD16+ subpopulations. Regarding GM-CSF versus M-CSF conditions, CD80 exhibited increased expression with M-CSF polarization in the CD14+CD16++ subpopulation. CD86 levels are higher with M-CSF polarization in CD14++CD16+ and CD14+CD16++ subpopulations. During either polarization condition, the CD14+CD16++ population was found to die more quickly than the other two.

Conclusions: Our study showed that under both M1 and M2 polarization conditions, peripheral monocyte subset-derived macrophages exhibit distinctive expression kinetics of immune biomarkers associated with ocular autoimmunity. Our results contribute to knowledge of the innate immune mechanisms involved in non-infectious uveitis.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×